Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)
摘要:
A structure-activity relationship study was conducted on a series of tetrahydro-beta-carboline-1-carboxylic acid analogs in order to identify the key functionality responsible for activity against the mitogen-activated protein kinase-activated protein kinase 2 enzyme (MK-2). The compounds were further evaluated for their ability to inhibit TNF alpha production in U937 cells and in vivo. These compounds represent a novel structural class of compounds capable of inhibiting MK-2 with remarkable selectivity. (c) 2007 Elsevier Ltd. All rialuts reserved.
Tetrahydro .beta.-carbolines having anti-hypertensive activity
申请人:Miles Laboratories, Inc.
公开号:US04291039A1
公开(公告)日:1981-09-22
Disclosed are novel tetrahydro .beta.-carbolines of the formula: ##STR1## wherein R is H, OCH.sub.3 or F; R.sub.1 is H or CH.sub.3 and R.sub.2 is H or COOR.sub.3 where R.sub.3 is H or CH.sub.3. These compounds are useful as antihypertensive agents.
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
申请人:Anderson R. David
公开号:US20050137220A1
公开(公告)日:2005-06-23
A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject a beta-carboline MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.
Tetrahydro .beta.-carbolines having antihypertensive activity
申请人:Miles Laboratories, Inc.
公开号:US04361566A1
公开(公告)日:1982-11-30
Disclosed are novel tetrahydro .beta.-carbolines of the formula: ##STR1## wherein R is H, OCH.sub.3 or F; R.sub.1 is H or CH.sub.3 and R.sub.2 is H or COOR.sub.3 where R.sub.3 is H or CH.sub.3. These compounds are useful as antihypertensive agents.